Jonathan A. Ship, DMD | Authors

SAV-RITE PHARMACY LLC

1234 ABBOTT RD STE 210

Articles

Commentary (Ship): Management of Xerostomia Related to Radiotherapy for Head and Neck Cancer

December 01, 2005

In 2005, an estimated 29,370 newcases of oral cavity and pharyngealcancers were diagnosed inthe United States, accounting for2.14% of all cancer cases.[1] Over7,000 individuals will die from thesecancers in this country in 2005-approximately one death per hour.Many advances have been made inthe diagnosis and treatment of thesecancers, yet the mortality rate remainshigh (5-year survival rate of ~50%).Probably the most important approachis early detection, since early-stagetumors are associated with markedlybetter survival rates than late-stagecancers that have already spread toregional tissues and lymphatics.